In: European Journal of Nuclear Medicine and Molecular Imaging, 2015, vol. 42, no. 1, p. 128-137
|
In: Cerebral Cortex, 2017, vol. 27, no. 6, p. 3272-3283
|
In: Human Molecular Genetics, 2017, vol. 26, no. 18, p. 3453-3465
|
In: Neurocritical Care, 2015, vol. 22, no. 2, p. 243-250
|
In: Plos pathogens, 2018, vol. 14, no. 10, p. e1007335
Antibodies to the prion protein, PrP, represent a promising therapeutic approach against prion diseases but the neurotoxicity of certain anti-PrP antibodies has caused concern. Here we describe scPOM-bi, a bispecific antibody designed to function as a molecular prion tweezer. scPOM-bi combines the complementarity-determining regions of the neurotoxic antibody POM1 and the neuroprotective...
|
In: ADHD Attention Deficit and Hyperactivity Disorders, 2014, vol. 6, no. 3, p. 175-202
|
In: Psychopharmacology, 2009, vol. 202, no. 1-3, p. 371-384
|
In: Experimental Brain Research, 2005, vol. 161, no. 3, p. 351-357
|
In: Journal of Neural Transmission, 2009, vol. 116, no. 9, p. 1053-1057
|
In: Experimental Brain Research, 2013, vol. 225, no. 4, p. 527-534
|